AngioDynamics, Inc. (Nasdaq:ANGO) announced on Tuesday November 30, 2010 that it will present at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference, to be held December 7-8, 2010, at the Nikko Hotel in San Francisco. On Tuesday, December 7, at 2:30 p.m. PT, AngioDynamics’ President and Chief Executive Officer Jan Keltjens will review the Company’s business strategy and recent corporate developments.
AngioDynamics, Inc. (AngioDynamics) is a provider of medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease (NYSE:PVD) and local oncology therapy options for treating cancer, including radiofrequency ablation (NYSEMKT:RFA) systems.
American Video Teleconferencing Corp. (Pink Sheets:AVOT) is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file.
Also the company will not be proceeding with the option agreement on the three claim blocks in Northern Saskatchewan as announced on Nov. 29, 2010. The company believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings.
As neither the Federal nor Quebec Governments have carried out any air borne surveys in this area, the company will seek a contractor to do an air borne Mag-EM radiometric survey. This survey will cover its present holdings and the immediate surrounding area looking for future acquisitions. We are pleased to be working in the Province of Quebec as it is rated the number one jurisdiction in the world to carry out mineral exploration.
The Quebec Government gives a rebate up to 45% for property expenditures.
Presently the company is in the final stage of negotiations with Kondor Gold Pyt. in Australia.
The company will aggressively continue to search world-wide for opportunities in Precious, Base and Rare Earths metal projects.
Intersil Corporation (Nasdaq:ISIL) on Monday December 6, 2010 its annual Intersil Engineering Conference (NYSEMKT:IEC) December 7-9 at the company's headquarters in Milpitas, California. The conference, which has been held annually since 2007, allows Intersil engineers company-wide to convene and share knowledge, best practices and technology breakthroughs.
Intersil Corporation (Intersil) designs, develops, manufactures and markets high-performance analog integrated circuits (ICs). The Company’s product portfolio addresses some of the applications in four end markets.
Power3 Medical Products Inc. (OTC:PWRM) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
Alzheimer’s disease isn’t an ordinary part of getting older, even though this greatest known risk factor is increasing, along with the largest part of people today with Alzheimer’s tend to be 65 and older. But Alzheimer’s is not just a sickness of old age. Up to 5 % of people with the sickness currently have early-onset Alzheimer’s (also referred to as younger-onset), which frequently appears when ever someone is within his or her 40s or 50s.
PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials.
These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
For more information about this company please visit http://www.power3medical.com
Intevac, Inc. (Nasdaq:IVAC) announced on Tuesday November 30, 2010 it has acquired Solar Implant Technologies (SIT). SIT has developed a novel concept for a compact ion implant module to provide improved doping of silicon photovoltaic cells.
Ion implant, a proven technology in semiconductor manufacturing, has recently been adapted for use in the manufacturing of photovoltaic cells to improve the conversion efficiency of silicon cells.
Intevac, Inc. (Intevac) provides manufacturing equipment and solutions to the hard disk drive industry and offers solutions to the photovoltaic (PV) and semiconductor industries. The Company operates in two segments: Equipment and Intevac Photonics.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates to receive 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (OTCPK:AVOT) from the company for 12 months IR Services.
Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB.